News
Novartis Canada is pleased to announce that Fabhalta® (iptacopan capsules) is now available across Canada for adult patients ...
European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S.
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesCompany aims to accelerate access to much-needed biosimilar to reference ...
IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition marked by the accumulation of IgG4-positive plasma ...
By Oliver Hirt ZURICH (Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in ...
The "Deep Dive into Renewable Energy Procurement" report has been added to ResearchAndMarkets.com's offering.This report looks at the different procurement methods companies can use when adopting ...
Job Title Sort ascending Business Location Site Date Posted Medical Affairs Lead Regolare, Full time Germany +Alternative Locations Munich (Non-Sales Force) (Novartis Pharma GmbH) Apr 11, 2025 ...
Munich (Non-Sales Force) (Novartis Pharma GmbH) Apr 11, 2025 Medical Affairs Lead Regular, Full time Germany +Alternative Locations Munich (Non-Sales Force) (Novartis Pharma GmbH) Apr 11, 2025 Start ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results